Resmed Inc. buy KeyCorp
Start price
26.04.24
/
50%
€190.40
Target price
26.04.25
€222.05
Performance (%)
10.61%
End price
27.04.25
€210.60
Summary
This prediction ended on 27.04.25 with a price of €210.60. The prediction had a final performance of 10.61%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.93 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -0.181% | -0.181% | -2.608% |
| iShares Core DAX® | 0.760% | -0.301% | 17.507% |
| iShares Nasdaq 100 | 0.732% | -1.001% | 9.349% |
| iShares Nikkei 225® | 1.025% | -3.621% | 12.862% |
| iShares S&P 500 | -0.036% | -0.194% | 3.758% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten